is identified by an acute decline in renal function ultimately accompanied by the disruption of fluid, electrolyte, and metabolic homeostasis. The severity of AKI ranges from mild changes in biochemical markers to profound kidney damage requiring temporary or permanent renal replacement therapy. 3 The development of AKI is related to increased patient morbidity, including increased intensive care unit use and overall length of stay, increased rates of nonrenal and additional renal complications, and the risk for permanent renal damage.
1,2,4,5 On a systems level, AKI also contributes to increased institutional expense based on the need for additional procedures and longer length of stay. 3 The adoption of enhanced recovery protocols (ERP) has increased over the past several years, and many prospective and observational studies have highlighted their safety and ability to decrease length of stay, overall morbidity, and hospital costs. [6] [7] [8] [9] The focus on judicial intravenous fluid management, more liberal use of vasopressors to avoid excessive intraoperative fluid resuscitation, and administration of nonsteroidal anti-inflammatory drugs (NSAIDs) to limit narcotic use are fundamental to these protocols, with the overall goal of hastening return to bowel function. [10] [11] [12] [13] However, because of these basic tenants, there is concern that the use of ERPs may result in an increased rate of postoperative AKI. To address this concern, we aimed to identify independent risk factors for AKI in our colorectal surgery population with the hypothesis that adoption of an ERP would be associated with an increased rate of postoperative AKI.
PATIENTS AND METHODS
After obtaining institutional review board approval, a retrospective cohort study was conducted including all patients ≥18 years of age who underwent elective colorectal surgery before (January 1, 2010, to August 5, 2013) and after (August 6, 2013, to January 31, 2016) implementation of an ERP. Patients were followed through 30 postoperative days. Readmissions were captured for each patient, but a readmission was not counted as a new patient.
All of the cases were performed at a single academic institution by 1 of 2 board-certified colon and rectal surgeons. The primary outcome of AKI was defined as a rise in serum creatinine to a value ≥1.5 times the preoperative baseline value within 30 days of surgery (eg, 1.0-1.5 mg/dL) based on the most recent clinical practice guidelines from the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. 14 It is important to note that the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) defines progressive renal insufficiency as a decreased ability of the kidney to perform its usual function, which is indicated by a rise in serum creatinine of >2 mg/dL from the preoperative value (eg, 1 mg/dL to 3 mg/dL), but without the need for dialysis within 30 days postoperatively. Acute renal failure is defined as the postoperative deterioration of renal function to the point of requiring dialysis within 30 days postoperatively in a patient that did not require preoperative dialysis. However, we elected to use the more liberal KDIGO definition of AKI, as defined above, as the primary outcome of this study given its greater sensitivity to capture more patients with less significant, yet likely clinically relevant, creatinine elevations in the postoperative period. Other secondary outcomes included postoperative complications based on NSQIP definitions (surgical site infection, wound disruption, postoperative pneumonia, unplanned intubation, pulmonary embolism, postoperative ventilator dependency for >48 h, urinary tract infection, cerebrovascular accident, cardiac arrest, myocardial infection, postoperative transfusion within 72 h, vein thrombosis requiring therapy, postoperative sepsis/septic shock, and other postoperative occurrences), postoperative hemodialysis, length of stay, 30-day readmissions, and mortality.
Data Collection
Patients were identified from a prospectively collected database supplemented by data from the NSQIP database. NSQIP definitions for all demographics and outcome variables were used and can be found at https://www. facs.org/~/media/files/quality%20programs/nsqip/nsqip_ puf_user_guide_2015.ashx. Glomerular filtration rate was calculated and patients were stratified into chronic kidney disease (CKD) stages 1 through 5. Chronic renal insufficiency was defined as stage 3 or 4 CKD. Patients with stage 5 CKD (glomerular filtration rate <15 mL/min or treatment by dialysis) were excluded.
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ERP Implementation
The preoperative and postoperative management strategies for the intervals before and after the implementation of the ERP have been described previously in detail. [10] [11] [12] [13] Before adoption of the protocol, patients were instructed to ingest only liquids the day before scheduled surgery, transitioning to taking nothing by mouth at midnight. In addition, a mechanical bowel preparation was used on the day before surgery. In general, pain management strategies included a low thoracic epidural with intravenous (IV) opioids as needed for open procedures and patientcontrolled analgesia with IV opioids for laparoscopic procedures before transition to oral opioids. NSAIDs were also used; however, there was no standard protocol before ERP implementation, and thus these patients received NSAIDs sporadically. Intraoperative IV fluid management was dictated by the anesthesia team. Postoperative IV fluid was managed by the surgical team, and decisions regard-ing diet advancement were left to the discretion of the primary surgeon. 8 Perioperative care was standardized on August 6, 2013, with the initiation of a colorectal surgery ERP. Patients were instructed to cease intake of solid foods at 6:00 PM on the evening before surgery. At this time, a mechanical bowel preparation was started. Intake of clear liquids was permitted until 2 hours before surgery, including a mandatory 20 ounces of Gatorade Thirst Quencher (PepsiCo, Purchase, NY) 2 hours before induction. Intraoperative anesthesia care was standardized as part of the protocol. For the first 6 months after ERP implementation, a dedicated group of 6 anesthesiologists and certified registered nurse anesthetists managed the anesthesia care. After this time, care of ERP patients was opened to all anesthesia practitioners. Intraoperative fluid management was guided by a goal-directed fluid algorithm, with more liberal use of intraoperative vasopressors to maintain satisfactory hemodynamics. 8 Postoperative IV fluids were continued at 40 mL/h until the morning of postoperative day (POD) 1, at which time a soft diet was initiated. Regarding pain management, neuraxial analgesia was administered preoperatively with a single shot of intrathecal morphine, and IV ketamine and lidocaine were infused throughout the surgery. Postoperatively, patients received IV lidocaine, oral acetaminophen, and NSAIDs, in addition to oral opioids for breakthrough pain. 8 More specifically, patients received 200 mg of oral celecoxib in the surgical admissions suite. Postoperatively, patients were treated with 100 mg of oral celecoxib twice daily. The only exceptions to celecoxib administration were for patients with a history of coronary artery disease or allergy to the medication. The patients were encouraged to take ibuprofen as needed after discharge but were not given a prescription.
Statistical Analysis
Separate univariate analyses were conducted to evaluate for differences in baseline characteristics between patients treated before and after ERP implementation, as well as patients with and without AKI. Differences in outcomes were compared using the χ 2 test for categorical variables and Student t test for continuous variables. Given an estimated baseline AKI rate of 12% in the pre-ERP population and a predicted increase in the AKI rate to 20% in the ERP group, 706 patients were required to achieve statistical power (1 -β) of 0.80.
Finally, a multivariable logistic regression model was then created to identify risk factors for AKI. Dependent variables were chosen a priori based on clinical factors shown previously to affect AKI development. A p value of 0.05 was used for statistical significance. All of the statistical analyses were performed using SAS 9.4 (SAS Institute, Cary, NC).
RESULTS
Nine-hundred patients were identified from the database between January 2010 and January 2016. A total of 461 patients (51.22%) underwent surgery before implementation of the ERP, and 439 patients (48.78%) underwent surgery after implementation. Demographic variables, procedural characteristics, and outcome variables for the 2 groups are reported in Table 1 . The ERP group had a higher rate of laparoscopic procedures, longer operating room time, and less blood loss. Urine output was lower in the ERP group on POD 0 but not on POD 1. ERP implementation also resulted in less fluid administration on POD 0 (4104.39 ± 2255.67 mL vs 1840.96 ± 1327.85 mL; p < 0.0001) and POD 1 (3623.66 ± 1338.29 mL vs 2312.30 ± 2111.02 mL; p < 0.0001), as well as higher use of NSAIDs and intraoperative vasopressors. Overall complications, length of stay, and 30-day readmissions were all decreased in the ERP group. There was no difference in the rate of AKI between the groups (p = 0.50).
Acute Kidney Injury
A total of 114 cases were complicated by AKI, with 55 cases (11.93%) identified in the pre-ERP group and 59 cases (13.44%) in the ERP group. A histogram demonstrating the difference between preoperative and maximum postoperative creatinine values for each patient within 30 days of surgery for each time period is shown in Figure 1 . Demographic variables, procedural characteristics, and outcome variables for patients with and without AKI are reported in Table 2 . Patients diagnosed with AKI were older with a higher BMI. Hypertension was more common in the AKI patients, but rates of diabetes mellitus and preoperative renal insufficiency did not differ between the groups. More patients with AKI underwent open surgery with longer operating room times and more blood loss. The presence of an ileostomy was also more common among patients with AKI. The use of NSAIDs was not more frequent in the AKI patients. The proportion of patients in the ERP group did not differ among those with and without AKI (p = 0.50). Importantly, patients with AKI had a longer length of stay and were more likely to experience a postoperative complication, including surgical site infection, 30-day readmission, and mortality.
Finally, a multivariable logistic regression model was developed to identify risk factors for AKI (Table 3) . Hypertension (p = 0.001), functional status (p = 0.02), ureteral stent (p = 0.04), NSAIDs (p = 0.02), operating time >200 minutes (p = 0.03), and increased IV fluid administration on POD 1 (p = 0.001) were all associated with an increased risk of AKI. Open surgery was also associated with an increased risk of AKI (p = 0.0008). The ERP was not independently associated with AKI (p = 0.09). The Cstatistic for the model was 0.84. 
DISCUSSION
The overall incidence of AKI in this study using the KDI-GO guideline definition was 12.67%, with approximately the same percentage occurring both before and after implementation of an ERP. 14 Contrary to our hypothesis, the implementation of a highly standardized ERP did not seem to be associated with an increased risk of AKI. However, we were able to identify multiple other risk factors for the development of AKI that could be used to alter management in these high-risk patients.
The incidence of AKI in our study is comparable to published rates of postoperative AKI after both major noncardiac surgery and, more specifically, after major intra-abdominal surgery.
1,2 The definition of AKI used in the current study (a rise in creatinine to a value ≥1.5 times the preoperative baseline value) was based on the most recent clinical practice guidelines from KDIGO, which were intended to replace the risk, injury, failure, loss of kidney function, and end-stage renal failure criteria. Although this definition may seem quite liberal (eg, identifying a patient with a creatinine that rose from 0.6 mg/dL to 0.9 mg/dL), recent data suggest that perioperative AKI is a frequently underrecognized condition. 16 Studies in postmyocardial infarction and critically ill patient populations have shown that the KDIGO criteria are more sensitive in identifying clinically significant AKI and subsequent mortality when compared with other definitions, such as the risk, injury, failure, loss of kidney function, and end-stage renal failure criteria. 17, 18 In the current study, there were very few patients with normal creatinine levels who met the definition for AKI (<10%). As demonstrated in Table 2 , the average peak creatinine for the AKI group was 2.13 mg/dL, and the outcomes for patients with AKI were significantly worse (including mortality) compared with those without AKI, further demonstrating the clinical relevance of the KDIGO definition in this colorectal surgery population.
Multiple retrospective and prospective observational studies have sought to identify predictors for AKI, both in the generalized patient population as well as in postoperative patients. Many of the identified risk factors exhibit overlap in the previously published literature and with the current study including ASA classification and hypertension. 2, 5, 19 In addition, our data identified associations among functional status, prolonged operating time (>200 min), prophylactic ureteral stents, and NSAID use with AKI. Similar to ASA classification, functional status captures a measure of a patient's overall health and is therefore not a surprising finding. Open surgery was also found to be a risk factor for AKI. Patients undergoing both open and prolonged operations will experience larger insensible water losses when compared with laparoscopic or shorter-duration procedures, which may at least partially explain this association. 20, 21 The multivariable logistic regression model also identified an association between increased IV fluid administration on POD 1 with postoperative AKI. It is impossible to discern a causal relationship between the increased volume of IV fluid on POD 1 and AKI in this retrospective study. More likely, the association between increasing IV fluid intake and AKI identified in this study reflects a reactive intervention to address the decreasing urine output signifying progression of renal injury rather than a true risk factor for AKI development.
Aggressive fluid resuscitation has nonetheless been the fundamental belief of many surgeons and anesthesiologists. However, emerging data suggest that too much fluid may, in fact, be harmful. 22, 23 As such, reduction in IV fluids has become one of the fundamental concepts central to ERPs. Goal-directed therapy (GDT), with the use of either invasive or noninvasive monitoring, is used in our ERP for intraoperative guidance of fluid and vasopressor management. Numerous randomized controlled trials have investigated renal outcomes after isolated GDT-outside of its use in enhanced recovery-with mixed results. Some studies have found a decrease in rates of postoperative AKI with the use of GDT, whereas others have found no superior renal outcomes with GDT as compared with standard clinical care. Notably, there are no studies that indicate that GDT leads to worse renal outcomes, which is also supported by the current analysis. 24, 25 Despite the existing evidence supporting the use of ERPs, there is a paucity of research on their potential effect on the development of AKI. In the United States, ERPs were first implemented in the colorectal surgery population and have gained in popularity after demonstrating improvements in clinical outcomes including substantial reductions in overall complications, length of stay, and healthcare expenditures. 8, 26, 27 Guiding principles of enhanced recovery call for a reduction in administered volumes of IV fluid and the use of NSAIDs to spare opioid medications to expedite return of bowel function. Because both of these individual components can lead to AKI via decreased renal perfusion, it is logical for there to be concern for increased rates of postoperative AKI with their use in ERPs. 28, 29 Despite these concerns, this study would suggest that the implementation of a highly standardized colorectal ERP does not have a significant impact on AKI.
This study is the largest to date to evaluate the effect of enhanced recovery implementation on the development of AKI. In addition, the definition of AKI used in this study is more restrictive than the NSQIP definition, enabling the identification of additional true AKI cases and making it more likely to detect an association between AKI and the protocol, if one existed. 30 Despite these strengths, there are several notable limitations to this study. AKI development commonly occurs secondary to other severe postoperative complications, such as sepsis from anastomotic leak, bleeding, or cardiac events. Because the implementation of the colorectal ERP also resulted in a significant decrease in the overall complication rate, it is possible that this diluted out any negative effect of the protocol on the overall rate of AKI. 8 To further investigate the relationship between the development of compli- cations and AKI, the diagnosis of AKI was removed from the definition of complication(s) and presented in Table 2 . There was a complication rate of 30% in those without AKI versus 39% in those with AKI (p = 0.04). A separate multivariable regression was performed, replacing the ERP with overall complications to assess the possible relationship of complications (excluding AKI) and AKI. Complications were not significantly associated with AKI (OR = 0.90 (95% CI, 0.54-1.49); p = 0.69; see Supplemental Table 1 , http:// links.lww.com/DCR/A569). In addition, AKI has been associated with many other factors, including hyperglycemia, hypoalbuminemia, and hyperuricemia, which could not all be taken into account in the current study. 31 The before-and-after study design predisposes toward the introduction of selection bias, although this is somewhat mitigated by the inclusion of potential confounders in the multivariable logistic regression model. In addition, all of the patients are put on the ERP despite medical comorbidities or extent of surgical procedure, further limiting the possibility for selection bias. Although the necessary sample size was exceeded to achieve statistical power of 0.80, the possibility of a type II error cannot be excluded to identify a smaller-than-expected effect on the development of AKI.
These results suggest that a well-organized and institutionally supported ERP can be implemented safely without an increase in AKI. This is, however, a single-institution study. Because ERPs vary widely between institutions, caution must be taken in generalizing these results to other protocols. As such, additional studies are warranted to validate our results.
CONCLUSION
This study identified similar rates of AKI before and after implementation of a highly standardized ERP in patients undergoing colorectal surgery. However, independent predictors of AKI were identified and could be used to alter the protocol in high-risk patients, including those with poor functional status, hypertension, or undergoing complex and prolonged open cases, particularly in the presence of a ureteral stent. Potential ERP modifications include avoidance of NSAIDs in all high-risk patients and implementation of renal protective strategies such as vigilant avoidance of hypotension in patients with a history of hypertension. Future prospective study is needed to determine whether protocol modifications will further decrease rates of AKI in this patient population.
